| CAS ID: | 77431-55-1 |
| Molecular Formula: | C17H37N3O6 |
| Molecular Weight: | 379.5 g/mol |
| Monoisotopic Mass: | 379.268 g/mol |
| Class: | Peptide |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 28212548 | Target ID | |
| Uniprot ID | Name | ||
| Model | vitro,mice | Fibrosis Disease | Liver fibrosis |
| Process I | attenue inflammation | ||
| Process II | HSCs-to-myofibroblasts | ||
| Process III | prevenet collagen deposition | ||
| Mechanism | Targeting NFY and p300 | ||
Trial Record 1
| ClinicalTrial ID | NCT02837302 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Unknown |
| First Received | July 19, 2016 | Last Verified | October 31, 2016 |
| Sponsor | Kyungpook National University | ||
| PubChem: | 9907842 |
| ChEMBL: |